Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 604
Selected: 0
NCT IDTitle
NCT06295159Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma
NCT03511196Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer
NCT03424837A Survivorship Care Plan and Embedded Navigation Tool
NCT02313272Hypofractionated Stereotactic Irradiation (HFSRT) With Pembrolizumab and Bevacizumab for Recurrent High Grade Gliomas
NCT00005793A Phase I/II Study of Induction Chemotherapy With Daunorubicin, Cytarabine, Topotecan and Etoposide
NCT00504257Avastin in Combination With Docetaxel in Ovarian/Fallopian Tube/Peritoneum Carcinoma
NCT03784924EDRN Prostate MRI Biomarker Study
NCT00325416Study of Melphalan and Topotecan (MT) Followed by Autologous Stem Cell Rescue in Patients With Multiple Myeloma.
NCT03406715Combination Immunotherapy-Ipilimumab-Nivolumab-Dendritic Cell p53 Vac - Patients With Small Cell Lung Cancer (SCLC)
NCT02247115Rapid Assessment of Trainee Endoscopy Skills (RATES) Study
NCT02336984A Phase I/II Trial of HER-2/Neu Pulsed DC1 Vaccine Combined With Trastuzumab for Patients With DCIS
NCT00496223A Phase I/II Study of Sunitinib and Dacarbazine
NCT05271630Multiple Myeloma Outcomes Based on Maintenance Therapy Post Autologous Stem Cell Transplant
NCT02948946Clinical Utility Assay as a Biomarker for Gastroenteropancreatic and Lung Neuroendocrine Tumors
NCT01253161Study of Pasireotide Long Acting Release (LAR) in Patients With Metastatic Neuroendocrine Tumors (NETs)
NCT03018223Calcineurin Inhibitor-Free GVHD Prevention Regimen After Related Haplo PBSCT
NCT06745882Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLC
NCT05004662Partnering With Food Bank to Provide Tobacco Treatment to Underserved Smokers
NCT01754623GTX-RT in Borderline Resectable Pancreatic Cancer
NCT05127174Maintenance Fedratinib to Prevent Post-Transplant Relapse in Myeloproliferative Neoplasms
NCT07101861Breast Cancer Survivors RESET (Reducing Weight and Elevated Stress Levels Using Educational and Behavioral Tools): A Pilot, Feasibility Study
NCT05524935Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma
NCT04975152Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma
NCT00815750Decision Making in Unaffected First-Degree Relatives of Prostate Cancer Patients
NCT05379933Caregiver Protocol for Remotely Improving, Monitoring, and Extending Quality of Life
NCT04101526Developing and Testing a Spanish-Language Intervention to Reduce Cancer-Related Sleep Disturbance
NCT01999985Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)
NCT01434550Phase II Study of First-line SBRT in Patients With Non-Metastatic Unresectable Pancreatic Cancer
NCT01042535Vaccine Therapy and 1-MT in Treating Patients With Metastatic Breast Cancer
NCT03377023Phase I/II Study of Nivolumab and Ipilimumab Combined With Nintedanib in Non Small Cell Lung Cancer
NCT01842646Phase II Hedgehog Inhibitor for Myelodysplastic Syndrome (MDS)
NCT00012350Phase II Evaluation of FTase Inhibitor (FTI)in Treatment of Advanced Multiple Myeloma
NCT03517995Randomized, Phase II Clinical Trial of Sulforaphane in Bladder Cancer Chemoprevention
NCT00351039Phase I/II Trial of Bevacizumab, Pemetrexed and Erlotinib in Elderly Patients With Non-Small Cell Lung Cancer
NCT06337552High-Fermented Food Intervention Among Locally Advanced Rectal Cancer Patients (The FEED Trial)
NCT04091165Mobile APP Utilization for Enhanced Post-Operative Nutritional Recovery
NCT00660400Pre-Transplant 5-Azacitidine In Patients With High-Risk Myelodysplastic Syndrome Who Are Candidates For Allogeneic Hematopoietic Cell Transplant
NCT04620681CD8 Depleted, Non-engrafting, HLA Mismatched Unrelated Infusion With MDS and Secondary AML
NCT00006032Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer
NCT03807765Stereotactic Radiation and Nivolumab in the Management of Metastatic Breast Cancer Brain Metastases
NCT05681780Clinical Trial of CD40L-Augmented TIL for Patients With EGFR, ALK, ROS1 or HER2-Driven NSCLC
NCT03874325Aromatase Inhibitor and Durvalumab in Postmenopausal Breast Cancer
NCT01483664Communication Skills Intervention to Promote Transition Into Survivorship
NCT03598309Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers
NCT04252612Biological Outcomes of Pramlintide in Resectable Cutaneous Squamous Cell Carcinoma: A Pilot Study
NCT05108428Adaptive Radiation for Locally Advanced Rectal Adenocarcinoma
NCT04160065Immunotherapy With IFx-Hu2.0 Vaccine for Advanced Non-melanoma Skin Cancers
NCT05438940Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Gastroesophageal Cancer (GEC) Patients
NCT07033598Pacritinib vs. Hydroxyurea in Advanced Proliferative Chronic Myelomonocytic Leukemia
NCT06199726REFLECT: Reproductive Education and Fertility Links for Cancer Treatment